Moringa oleifera Lamk. as a Promising Adjunct Therapeutic Candidate: A Narrative Review of Human Studies and Published Case Reports

This narrative review examined human studies and case reports investigating Moringa oleifera as a potential therapeutic adjunct treatment. The researchers systematically collected and analyzed published clinical evidence to evaluate moringa's therapeutic potential across various health conditions. A narrative review differs from a systematic review in that it provides a broader, more interpretive analysis of the literature rather than following strict quantitative synthesis protocols. The authors aimed to synthesize existing human evidence to determine whether moringa shows promise as a complementary therapeutic option. The review found that while some human studies suggest potential benefits of moringa supplementation, the overall quality of evidence remains limited. The researchers identified gaps in current research methodology and highlighted the need for more rigorous clinical trials. This matters because moringa is increasingly marketed as a health supplement, yet comprehensive reviews of human evidence are scarce. The findings suggest that while preliminary human data shows some promise, much more robust clinical research is needed before moringa can be confidently recommended as a therapeutic adjunct. This review provides healthcare practitioners and researchers with a consolidated overview of the current state of human moringa research, helping to identify both the potential opportunities and significant limitations in the existing evidence base.